US Stock MarketDetailed Quotes

Connect Biopharma (CNTB)

Watchlist
  • 2.520
  • 0.0000.00%
Close Apr 24 15:59 ET
  • 2.495
  • -0.025-0.98%
Post 19:13 ET
142.43MMarket Cap-2.52P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Connect Biopharma (CNTB) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
-99.75%64K
0
-98.69%16K
-99.80%48K
0
26.03M
698K
1.22M
24.12M
0
Operating revenue
-99.75%64K
--0
-98.69%16K
-99.80%48K
--0
--26.03M
--698K
--1.22M
--24.12M
--0
Cost of revenue
Gross profit
Operating expense
19.91%58.14M
50.49%15.53M
17.44%17.69M
28.67%13.47M
-9.39%11.45M
-29.79%48.49M
10.32M
15.07M
10.47M
12.63M
Selling and administrative expenses
5.78%20.34M
3.99%4.24M
8.70%6.58M
-8.26%4.7M
21.26%4.81M
19.78%19.23M
--4.08M
--6.06M
--5.12M
--3.97M
-General and administrative expense
5.78%20.34M
3.99%4.24M
8.70%6.58M
-8.26%4.7M
21.26%4.81M
19.78%19.23M
--4.08M
--6.06M
--5.12M
--3.97M
Research and development costs
29.20%37.8M
80.92%11.28M
23.32%11.11M
64.04%8.77M
-23.43%6.63M
-44.80%29.26M
--6.24M
--9.01M
--5.35M
--8.66M
Operating profit
-158.66%-58.07M
-61.41%-15.53M
-27.67%-17.68M
-198.37%-13.42M
9.39%-11.45M
67.49%-22.45M
-9.62M
-13.85M
13.65M
-12.63M
Net non-operating interest income expense
-49.07%2.27M
-54.77%384K
-51.98%545K
-49.35%619K
-42.26%720K
-14.74%4.45M
849K
1.14M
1.22M
1.25M
Non-operating interest income
-49.07%2.27M
-54.77%384K
-51.98%545K
-49.35%619K
-42.26%720K
-14.74%4.45M
--849K
--1.14M
--1.22M
--1.25M
Other net income (expense)
-79.84%523K
300.00%60K
93.52%-7K
-533.33%-39K
-81.31%509K
40.44%2.59M
-30K
-108K
9K
2.72M
Other non- operating income (expenses)
-79.84%523K
300.00%60K
93.52%-7K
-533.33%-39K
-81.31%509K
40.44%2.59M
---30K
---108K
--9K
--2.72M
Income before tax
-258.86%-55.28M
-71.39%-15.08M
-33.70%-17.14M
-186.33%-12.84M
-17.95%-10.22M
75.15%-15.41M
-8.8M
-12.82M
14.88M
-8.66M
Income tax
-11.66%197K
-74.53%27K
7.02%61K
83.33%55K
80.00%54K
85.83%223K
106K
57K
30K
30K
Net income
-255.00%-55.48M
-69.65%-15.11M
-33.58%-17.2M
-186.88%-12.9M
-18.16%-10.27M
74.84%-15.63M
-8.91M
-12.88M
14.85M
-8.69M
Net income continuous Operations
-255.00%-55.48M
-69.65%-15.11M
-33.58%-17.2M
-186.88%-12.9M
-18.16%-10.27M
74.84%-15.63M
---8.91M
---12.88M
--14.85M
---8.69M
Minority interest income
Net income attributable to the parent company
-255.00%-55.48M
-69.65%-15.11M
-33.58%-17.2M
-186.88%-12.9M
-18.16%-10.27M
74.84%-15.63M
-8.91M
-12.88M
14.85M
-8.69M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-255.00%-55.48M
-69.65%-15.11M
-33.58%-17.2M
-186.88%-12.9M
-18.16%-10.27M
74.84%-15.63M
-8.91M
-12.88M
14.85M
-8.69M
Basic earnings per share
-257.14%-1
-68.75%-0.27
-34.78%-0.31
-185.19%-0.23
-18.75%-0.19
75.22%-0.28
-0.16
-0.23
0.27
-0.16
Diluted earnings per share
-257.14%-1
-68.75%-0.27
-34.78%-0.31
-185.19%-0.23
-18.75%-0.19
75.22%-0.28
-0.16
-0.23
0.27
-0.16
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue -99.75%64K0-98.69%16K-99.80%48K026.03M698K1.22M24.12M0
Operating revenue -99.75%64K--0-98.69%16K-99.80%48K--0--26.03M--698K--1.22M--24.12M--0
Cost of revenue
Gross profit
Operating expense 19.91%58.14M50.49%15.53M17.44%17.69M28.67%13.47M-9.39%11.45M-29.79%48.49M10.32M15.07M10.47M12.63M
Selling and administrative expenses 5.78%20.34M3.99%4.24M8.70%6.58M-8.26%4.7M21.26%4.81M19.78%19.23M--4.08M--6.06M--5.12M--3.97M
-General and administrative expense 5.78%20.34M3.99%4.24M8.70%6.58M-8.26%4.7M21.26%4.81M19.78%19.23M--4.08M--6.06M--5.12M--3.97M
Research and development costs 29.20%37.8M80.92%11.28M23.32%11.11M64.04%8.77M-23.43%6.63M-44.80%29.26M--6.24M--9.01M--5.35M--8.66M
Operating profit -158.66%-58.07M-61.41%-15.53M-27.67%-17.68M-198.37%-13.42M9.39%-11.45M67.49%-22.45M-9.62M-13.85M13.65M-12.63M
Net non-operating interest income expense -49.07%2.27M-54.77%384K-51.98%545K-49.35%619K-42.26%720K-14.74%4.45M849K1.14M1.22M1.25M
Non-operating interest income -49.07%2.27M-54.77%384K-51.98%545K-49.35%619K-42.26%720K-14.74%4.45M--849K--1.14M--1.22M--1.25M
Other net income (expense) -79.84%523K300.00%60K93.52%-7K-533.33%-39K-81.31%509K40.44%2.59M-30K-108K9K2.72M
Other non- operating income (expenses) -79.84%523K300.00%60K93.52%-7K-533.33%-39K-81.31%509K40.44%2.59M---30K---108K--9K--2.72M
Income before tax -258.86%-55.28M-71.39%-15.08M-33.70%-17.14M-186.33%-12.84M-17.95%-10.22M75.15%-15.41M-8.8M-12.82M14.88M-8.66M
Income tax -11.66%197K-74.53%27K7.02%61K83.33%55K80.00%54K85.83%223K106K57K30K30K
Net income -255.00%-55.48M-69.65%-15.11M-33.58%-17.2M-186.88%-12.9M-18.16%-10.27M74.84%-15.63M-8.91M-12.88M14.85M-8.69M
Net income continuous Operations -255.00%-55.48M-69.65%-15.11M-33.58%-17.2M-186.88%-12.9M-18.16%-10.27M74.84%-15.63M---8.91M---12.88M--14.85M---8.69M
Minority interest income
Net income attributable to the parent company -255.00%-55.48M-69.65%-15.11M-33.58%-17.2M-186.88%-12.9M-18.16%-10.27M74.84%-15.63M-8.91M-12.88M14.85M-8.69M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -255.00%-55.48M-69.65%-15.11M-33.58%-17.2M-186.88%-12.9M-18.16%-10.27M74.84%-15.63M-8.91M-12.88M14.85M-8.69M
Basic earnings per share -257.14%-1-68.75%-0.27-34.78%-0.31-185.19%-0.23-18.75%-0.1975.22%-0.28-0.16-0.230.27-0.16
Diluted earnings per share -257.14%-1-68.75%-0.27-34.78%-0.31-185.19%-0.23-18.75%-0.1975.22%-0.28-0.16-0.230.27-0.16
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -